Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nymox Pharmaceutical Corp (NASDAQ:NYMX)

3.35
Delayed Data
As of 4:00pm ET
 -0.16 / -4.56%
Today’s Change
1.13
Today|||52-Week Range
4.37
+2.13%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues3.1M3.4M2.9M2.8M
 
 
 
 
 
Cost of Goods Sold253.9K486.2K173.7K160.3K
 
 
 
 
 
Depreciation And Amortization10.4K9.1K6.6K6.0K
 
 
 
 
 
 
Operating ExpensesGross Income2.8M2.9M2.8M2.6M
 
 
 
 
 
General Expenses10.7M8.3M7.8M20.3M
 
 
 
 
 
Research And Development8.6M6.3M4.8M8.6M
 
 
 
 
 
Total Operating Expenses11.0M8.8M7.9M20.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-7.9M-5.4M-5.0M-17.7M
 
 
 
 
 
Extraordinary Credit0.000.00189.6K0.00
 
 
Interest Expense On Debt0.00--86.8K187.8K
 
 
 
Other Expenses-39.1K-27.0K-24.6K-35.8K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-7.9M-5.5M-4.9M-17.9M
 
 
 
 
 
Income Taxes-289.8K-555.0K-316.8K0.00
 
 
 
 
Net Income-7.6M-4.9M-4.6M-17.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS33.2M34.1M35.3M37.4M
 
 
 
 
 
Shares To Calculate EPS Diluted33.2M34.1M35.3M37.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.23-$0.14-$0.13-$0.48
 
 
 
 
 
EPS Diluted-$0.23-$0.14-$0.13-$0.48